| Trial registration number
|
NCT05515081 |
Full text link
Last imported at : Aug. 26, 2022, 9 p.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT05515081
|
First author
Last imported at : Aug. 26, 2022, 9 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Contact
Last imported at : Aug. 26, 2022, 9 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : Aug. 26, 2022, 9 p.m.
Source : ClinicalTrials.gov
|
2022-08-25
|
Recruitment status
Last imported at : July 8, 2023, 8 a.m.
Source : ClinicalTrials.gov
|
Completed
|
Study design
Last imported at : Aug. 26, 2022, 9 p.m.
Source : ClinicalTrials.gov
|
nonRCT
|
Allocation
Last imported at : Aug. 26, 2022, 9 p.m.
Source : ClinicalTrials.gov
|
Non-randomized
|
Design
Last imported at : Aug. 26, 2022, 9 p.m.
Source : ClinicalTrials.gov
|
Single group assignment
|
Masking
Last imported at : Aug. 26, 2022, 9 p.m.
Source : ClinicalTrials.gov
|
Open label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : Aug. 26, 2022, 9 p.m.
Source : ClinicalTrials.gov
|
Prevention
|
Inclusion criteria
Last imported at : Sept. 1, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
• healthy adult subjects included in the vaccination program carried out for hospital staff of the san camillo and villa salus hospitals in venice starting from january 2021
|
Exclusion criteria
Last imported at : Sept. 1, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
• none
|
Number of arms
Last imported at : Aug. 26, 2022, 9 p.m.
Source : ClinicalTrials.gov
|
1
|
Funding
Last imported at : Aug. 26, 2022, 9 p.m.
Source : ClinicalTrials.gov
|
IRCCS San Camillo, Venezia, Italy
|
Inclusion age min
Last imported at : Aug. 26, 2022, 9 p.m.
Source : ClinicalTrials.gov
|
3
|
Inclusion age max
Last imported at : Aug. 26, 2022, 9 p.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : Aug. 26, 2022, 9 p.m.
Source : ClinicalTrials.gov
|
Italy
|
Type of patients
Last imported at : Aug. 26, 2022, 9 p.m.
Source : ClinicalTrials.gov
|
Healthy volunteers
|
Severity scale
Last imported at : Aug. 26, 2022, 9 p.m.
Source : ClinicalTrials.gov
|
N/A
|
Total sample size
Last imported at : Aug. 26, 2022, 9 p.m.
Source : ClinicalTrials.gov
|
200
|
primary outcome
Last imported at : Aug. 26, 2022, 9 p.m.
Source : ClinicalTrials.gov
|
Antibody titre assesssed by ELISA SARS-Cov-2 anti-RBD IgG kit
|
Notes
Last imported at : Aug. 26, 2022, 9 p.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Aug. 26, 2022, 9 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : Aug. 26, 2022, 9 p.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "nan", "treatment_id": 222, "treatment_name": "Bnt162b2", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}]
|